New York Attorney General Letitia James is demanding that NYU Langone Hospital in Manhattan restore gender-transition care for patients under 19, despite the hospital citing federal funding risks and regulatory concerns.

James’ office claims the hospital violated state anti-discrimination laws by ending its Transgender Youth Health Program, which provided puberty blockers, hormone therapy, and other gender-transition treatments to minors. In a Feb. 25 letter, the attorney general’s office warned NYU Langone that failure to resume treatments by March 11 could result in “further action.”

NYU Langone suspended the program after President Donald Trump signed an executive order aimed at restricting gender-transition care for people under 19, and the U.S. Department of Health and Human Services proposed cutting Medicaid and Medicare funding to hospitals offering such treatments. The hospital also cited the departure of its medical director and ongoing regulatory uncertainty in explaining the decision.

Critics say James’ intervention disregards the legal and financial pressures hospitals face, forcing medical providers to offer treatments that may conflict with federal guidance. The attorney general’s office insists the federal proposal does not alter hospitals’ obligations under New York law, but opponents warn the mandate risks exposing institutions to financial penalties or other liabilities.

Several hospitals nationwide have also paused transgender youth treatments following the Trump administration’s order, highlighting the clash between state officials like James pressing expansive mandates and federal policy restricting care. NYU Langone has not yet stated how it will respond to the attorney general’s directive.